Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. (NERV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NERV · as of Jun 9, 2026
Key Statistics
Explore Minerva Neurosciences, Inc. Data
nerv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 71.4%
The NERV analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +7.99% upside from the current price of $4.63.
Competitors & Peers
nerv competitorsNERV
CLGN
CVKD
ENLV
KLTO
NRSNStock Performance
Full HistoryAbout Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders af…
what is minerva neurosciences, inc. · nerv stock overview · minerva neurosciences, inc. company profile · who is minerva neurosciences, inc. ceo · nerv NASDAQ · minerva neurosciences, inc. headquarters · minerva neurosciences, inc. business segments
About Stock Overview & Key Data
Minerva Neurosciences, Inc. (NERV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 1, 2014. As of the latest trading session, NERV stock price is $4.63, with a market capitalization of $32.4M. The stock has returned +151.63% over the past 12 months and +15.17% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Minerva Neurosciences, Inc. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Minerva Neurosciences, Inc. reported revenue of — and net income of -$293.4M. For detailed data — including Minerva Neurosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Minerva Neurosciences, Inc. (NERV) stock price is $4.63. The stock is traded on NASDAQ under the ticker symbol NERV. The 52-week range is $1.57 – $12.46.